These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11131175)

  • 1. Association between Taq1 a dopamine D2 receptor polymorphism and psychopathology of schizophrenia in Japanese patients.
    Suzuki A; Kondo T; Mihara K; Furukori H; Nagashima U; Ono S; Otani K; Kaneko S
    Prog Neuropsychopharmacol Biol Psychiatry; 2000 Oct; 24(7):1105-13. PubMed ID: 11131175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between dopamine D2 receptor polymorphism at the Taq1 A locus and therapeutic response to nemonapride, a selective dopamine antagonist, in schizophrenic patients.
    Suzuki A; Mihara K; Kondo T; Tanaka O; Nagashima U; Otani K; Kaneko S
    Pharmacogenetics; 2000 Jun; 10(4):335-41. PubMed ID: 10862524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele.
    Thompson J; Thomas N; Singleton A; Piggott M; Lloyd S; Perry EK; Morris CM; Perry RH; Ferrier IN; Court JA
    Pharmacogenetics; 1997 Dec; 7(6):479-84. PubMed ID: 9429233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linkage and association of DRD2 gene TaqI polymorphism with schizophrenia in an Iranian population.
    Behravan J; Hemayatkar M; Toufani H; Abdollahian E
    Arch Iran Med; 2008 May; 11(3):252-6. PubMed ID: 18426314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between TaqI A dopamine D2 receptor polymorphism and therapeutic response to bromperidol: a preliminary report.
    Suzuki A; Kondo T; Mihara K; Yasui-Furukori N; Otani K; Furukori H; Kaneko S; Inoue Y
    Eur Arch Psychiatry Clin Neurosci; 2001; 251(2):57-9. PubMed ID: 11407439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D2 receptors binding potential is not affected by Taq1 polymorphism at the D2 receptor gene.
    Laruelle M; Gelernter J; Innis RB
    Mol Psychiatry; 1998 May; 3(3):261-5. PubMed ID: 9672902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between Taq1 A dopamine D2 receptor (DRD2) polymorphism and prolactin response to bromperidol.
    Mihara K; Suzuki A; Kondo T; Yasui-Furukori N; Ono S; Otani K; Kaneko S; Inoue Y
    Am J Med Genet; 2001 Apr; 105(3):271-4. PubMed ID: 11353448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The -141C Ins/Del polymorphism in the dopamine D2 receptor gene promoter region is associated with anxiolytic and antidepressive effects during treatment with dopamine antagonists in schizophrenic patients.
    Suzuki A; Kondo T; Mihara K; Yasui-Furukori N; Ishida M; Furukori H; Kaneko S; Inoue Y; Otani K
    Pharmacogenetics; 2001 Aug; 11(6):545-50. PubMed ID: 11505224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of aripiprazole and the Taq1A polymorphism in the dopamine D2 receptor gene on the clinical response and plasma monoamine metabolites level during the acute phase of schizophrenia.
    Miura I; Takeuchi S; Katsumi A; Mori A; Kanno K; Yang Q; Mashiko H; Numata Y; Niwa S
    J Clin Psychopharmacol; 2012 Feb; 32(1):106-9. PubMed ID: 22198450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin response to nemonapride, a selective antagonist for D2 like dopamine receptors, in schizophrenic patients in relation to Taq1A polymorphism of DRD2 gene.
    Mihara K; Kondo T; Suzuki A; Yasui N; Nagashima U; Ono S; Otani K; Kaneko S
    Psychopharmacology (Berl); 2000 Apr; 149(3):246-50. PubMed ID: 10823405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No relationship between Taq1 a polymorphism of dopamine D(2) receptor gene and extrapyramidal adverse effects of selective dopamine D(2) antagonists, bromperidol, and nemonapride in schizophrenia: a preliminary study.
    Mihara K; Suzuki A; Kondo T; Nagashima U; Ono S; Otani K; Kaneko S
    Am J Med Genet; 2000 Jun; 96(3):422-4. PubMed ID: 10898926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of dopamine D2 receptor gene polymorphisms as a possible predictor of treatment-resistance to dopamine antagonists in schizophrenic patients.
    Kondo T; Mihara K; Suzuki A; Yasui-Furukori N; Kaneko S
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Sep; 27(6):921-6. PubMed ID: 14499308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of the TaqI A polymorphism of the dopamine D(2) receptor gene with predisposition to neuroleptic malignant syndrome.
    Suzuki A; Kondo T; Otani K; Mihara K; Yasui-Furukori N; Sano A; Koshiro K; Kaneko S
    Am J Psychiatry; 2001 Oct; 158(10):1714-6. PubMed ID: 11579007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms of dopamine D2-like (D2, D3, and D4) receptors in schizophrenia.
    Ohara K; Nakamura Y; Xie DW; Ishigaki T; Deng ZL; Tani K; Zhang HY; Kondo N; Liu JC; Miyasato K; Ohara K
    Biol Psychiatry; 1996 Dec; 40(12):1209-17. PubMed ID: 8959285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene polymorphism influencing treatment response in psychotic patients in a naturalistic setting.
    Alenius M; Wadelius M; Dahl ML; Hartvig P; Lindström L; Hammarlund-Udenaes M
    J Psychiatr Res; 2008 Sep; 42(11):884-93. PubMed ID: 18086475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine D2 receptor gene polymorphisms predict well the response to dopamine antagonists at therapeutic dosages in patients with schizophrenia.
    Sakumoto N; Kondo T; Mihara K; Suzuki A; Yasui-Furukori N
    Psychiatry Clin Neurosci; 2007 Apr; 61(2):174-80. PubMed ID: 17362435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine D2 receptor promoter polymorphism: no association with schizophrenia.
    Tallerico T; Ulpian C; Liu IS
    Psychiatry Res; 1999 Feb; 85(2):215-9. PubMed ID: 10220012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine D2 receptor genotype is associated with increased mortality at a 10-year follow-up of alcohol-dependent individuals.
    Berggren U; Fahlke C; Berglund KJ; Wadell K; Zetterberg H; Blennow K; Thelle D; Balldin J
    Alcohol Alcohol; 2010; 45(1):1-5. PubMed ID: 19654188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine receptor D2 gene Taq1A (C32806T) polymorphism modifies the relationship between birth weight and educational attainment in adulthood: 21-year follow-up of the Cardiovascular Risk in Young Finns study.
    Keltikangas-Järvinen L; Elovainio M; Kivimäki M; Raitakari OT; Viikari JS; Lehtimäki T
    Pediatrics; 2007 Oct; 120(4):756-61. PubMed ID: 17908762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No association between the dopamine d2 receptor taqi a1 allele and earlier age of onset of alcohol dependence according to different specified criteria.
    Anghelescu I; Germeyer S; Müller MJ; Klawe C; Singer P; Dahmen N; Wetzel H; Himmerich H; Szegedi A
    Alcohol Clin Exp Res; 2001 Jun; 25(6):805-9. PubMed ID: 11410714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.